说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 慢性髓细胞白血病
1)  Chronic myeloid leukemia
慢性髓细胞白血病
1.
Chromosome analysis and quantification of bcr-abl fusion gene transcripts in patients with chronic myeloid leukemia: Value of clinical application;
慢性髓细胞白血病患者染色体分析及bcr/abl融合基因转录本定量的临床意义
2.
Immunoregulatory effects of interferon-α on dendritic cells from patients with chronic myeloid leukemia (Ⅱ);
α-干扰素对慢性髓细胞白血病来源的树突状细胞的免疫调节作用(Ⅱ)
3.
To investigate the karyotype of chronic myeloid leukemia in blast crisis (CML-BC), karyotype analysis was performed with R-banding technique in 119 patients with CML-BC.
为了探讨慢性髓细胞白血病急变期(CML-BC)核型变化规律及意义,应用R显带技术对119例CML-BC患者的核型资料进行分析,并在其中随机选出28例以荧光原位杂交法(FISH)检测衍生9号染色体[der(9)]是否缺失。
2)  Chronic myelogenous leukemia
慢性髓细胞白血病
1.
To observe the efficacy of allo-PBSCT in chronic myelogenous leukemia(CML), twelve patients with chronic phase CML were treated with allo-PBSCT.
为了评价异基因外周血造血干细胞移植 (allo PBSCT)治疗慢性髓细胞白血病 (CML)的疗效 ,作者对 12例CML进行了allo PBSCT的临床研究 ,12例均为第 1次慢性期 ,中位年龄 32 。
2.
Objective To monitor BCR-ABL fusion gene of chronic phase chronic myelogenous leukemia(CML-CP) dynamically, so as to evaluate the CML-CP patients response to imatinib mesylate.
目的:动态监测慢性髓细胞白血病慢性期(chronic phase chronic myeloidleukemia,CML-CP)患者伊马替尼治疗过程中BCR-ABL融合基因变化,以了解CML-CP患者对伊马替尼治疗的反应。
3)  CML
慢性髓细胞白血病
1.
This study was aimed to analyze the prognostic factors of the patients with chronic myeloid leukemia (CML).
本研究分析影响慢性髓细胞白血病(CML)患者预后的危险因素。
2.
The minimal residual disease (MRD) in 19 patients with chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) was detected by DD-FISH, and the detected results were compared with those of conventional cytogenetics (CC) and reverse transcription-polymerase chain reaction (RT-PCR).
对19例慢性髓细胞白血病(CML)异基因造血干细胞移植(allo-HSCT)后微小残留病灶(MRD)用DD-FISH进行监测,同时与常规细胞遗传学(CC)、逆转录-聚合酶链反应(RT-PCR)结果相比较。
3.
Many studies had shown that p210~(bcr-abl) play the key role in the pathogenesis of chronic myeloid leukemia (CML).
慢性髓细胞白血病(Chronic myeloid leukemia, CML)具有特征性的BCR-ABL融合基因。
4)  chronic myelogenous leukemia
慢性髓细胞性白血病
1.
Objective:To construct eukaryotic expression vector of siRNA specific for bcr/abl as a molecular target tool to cleave bcr/abl mRNA in chronic myelogenous leukemia cell, and to expore the feasibility of it.
目的:构建特异性的抗慢性髓细胞白血病融合基因bcr/ablmRNA的siRNA真核细胞表达载体,探索RNA干扰(RNAi)分子靶向治疗慢性髓细胞性白血病(CML)的作用。
2.
To clarify the association between HLA DPB1 alleles and chronic myelogenous leukemia (CML) in South Chinese, the allelic types of HLA DPB1 were detected by sequence based typing (SBT) in 86 patients with CML and 82 healthy individuals from Southern China.
为了探讨慢性髓细胞性白血病 (CML)与人类白细胞抗原 (HLA)DPB1基因的相关性和分析其遗传易感性 ,采用测序分型技术 (SBT)对 86例主要为广东藉的南方汉族CML患者和 82例健康对照者进行HLA DPB1基因分型。
3.
Objective: To investigate the effects of Calcium ionophore(CI) on the induction of chronic myelogenous leukemia cells into dendritic cells (CML-DCs).
目的:探讨钙离子载体诱导慢性髓细胞性白血病细胞分化生成树突状细胞的作用,探索一种更快速、简便、高效的获取大量树突状细胞的方法。
5)  Chronic myelocytic leukemia
慢性髓细胞性白血病
1.
Relationship of chronic myelocytic leukemia and angiogenesis factors;
慢性髓细胞性白血病与血管生成因子关系
6)  chronic myeloid leukemia cel l line
慢性髓性白血病细胞系
补充资料:慢性单核细胞白血病


慢性单核细胞白血病
chronic mon?ocytic leukemia;CMOL

  以单核细胞增多为特征的一种白血病。有的是慢性粒细胞白血病伴有单核细胞增多;有的则为慢性粒单细胞白血病,即骨髓增生异常综合征的一个亚型。
  
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条